179 related articles for article (PubMed ID: 15963059)
1. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
Greenman Y; Tordjman K; Osher E; Veshchev I; Shenkerman G; Reider-Groswasser II; Segev Y; Ouaknine G; Stern N
Clin Endocrinol (Oxf); 2005 Jul; 63(1):39-44. PubMed ID: 15963059
[TBL] [Abstract][Full Text] [Related]
2. Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.
Greenman Y; Cooper O; Yaish I; Robenshtok E; Sagiv N; Jonas-Kimchi T; Yuan X; Gertych A; Shimon I; Ram Z; Melmed S; Stern N
Eur J Endocrinol; 2016 Jul; 175(1):63-72. PubMed ID: 27150495
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
4. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
5. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
6. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas.
O'Sullivan EP; Woods C; Glynn N; Behan LA; Crowley R; O'Kelly P; Smith D; Thompson CJ; Agha A
Clin Endocrinol (Oxf); 2009 Nov; 71(5):709-14. PubMed ID: 19302582
[TBL] [Abstract][Full Text] [Related]
7. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
Honegger J; Ernemann U; Psaras T; Will B
Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
9. Non-functioning pituitary adenomas.
Chanson P; Brochier S
J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
[TBL] [Abstract][Full Text] [Related]
10. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.
Mortini P; Barzaghi R; Losa M; Boari N; Giovanelli M
Neurosurgery; 2007 Jun; 60(6):993-1002; discussion 1003-4. PubMed ID: 17538372
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
Kars M; Pereira AM; Smit JW; Romijn JA
Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
[TBL] [Abstract][Full Text] [Related]
14. [The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas].
Iwai Y; Yamanaka K; Yoshioka K; Yoshimura M; Honda Y; Matsusaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2005 Aug; 33(8):777-83. PubMed ID: 16095207
[TBL] [Abstract][Full Text] [Related]
15. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
[TBL] [Abstract][Full Text] [Related]
16. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
[TBL] [Abstract][Full Text] [Related]
18. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.
Greenman Y; Ouaknine G; Veshchev I; Reider-Groswasser II; Segev Y; Stern N
Clin Endocrinol (Oxf); 2003 Jun; 58(6):763-9. PubMed ID: 12780754
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumors.
Ciric I
Neurol Clin; 1985 Nov; 3(4):751-68. PubMed ID: 2867459
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]